Get the latest BioCryst Pharmaceuticals, Inc. BCRX detailed stock quotes, stock data, Real ⦠Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. In the short term (2weeks), BCRX's stock price should underperform the market by -0.19%.During that period the price should oscillate between -10.74% and +13.37%. BCRX Stock Forecast - Is BCRX a buy or sell? The company directors and management may have good odds in positioning the firm resources to exploit market volatility in March.The stock standard deviation of daily returns for 30 days investing horizon is currently 7.04. BCRX is higher by $0.61 from the previous closing price of $7.65 on volume of 5,929,634 shares. Find out now with a free analysis on BioCryst Pharmaceuticals. BCRX stock forecast Our latest prediction for Biocryst Pharmaceuticals Inc.'s stock price was made on the Aug. 11, 2020 when the stock price was at 3.96$.. If you had invested $1,000USD in BioCryst Pharmaceuticals stock on Mar 1994, it would be valued $1,899.20 today. Forecast Cash Runway: BCRX has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 24.6% each year. What is the 52 week high and low for Biocryst Pharmaceuticals (NASDAQ: BCRX)? Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. 04:16 PM ET Next Steps Explore more healthy companies in the Pharmaceuticals & Biotech industry. View real-time stock prices and stock quotes for a full financial overview. Stock market timing forecast. Plasma Protease C1 Inhibitor Market Research Report to 2028 Industry Size, Growth Share, Future Trends, Price, Top Key Players Review, Business Opportunities, Demand and Global Analysis by Forecast The Express Wire. Find real-time BCRX - BioCryst Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. pretiming Stock market timing forecast for the next 10 days, 10 weeks. ... May 12, 2021: EPS forecast ⦠Shares of NASDAQ:BCRX traded up $0.18 during mid-day trading on Wednesday, reaching $7.55. pretiming: BCRX stock price BCRX stock RSI chart BioCryst Pharmaceuticals stock price history. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.45 and a quick ratio of 1.40. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. Zacks Rank stock-rating system returns are computed monthly based on ⦠Post-Market 0.20 (1.79%) That is because the Jun 18, 2021 $14.00 Call had some of the highest implied volatility of all equity options today. RESEARCH TRIANGLE PARK, N.C., Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter and full year 2020... GlobeNewsWire - 3 weeks ago BCRX stock forecast for the next 10 days by pretiming. Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market. Company Name: BioCryst PharmaceuticalsInc., Stock Symbol: BCRX, Industry: Medical - Drugs, Total Posts: 4985, Last Post: 2/18/2021 11:29:25 PM BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) is 1.34% higher on its value in year-to-date trading and has touched a low of $1.58 and a high of $8.99 in the current 52-week trading range. The high price target for BCRX is $16.00 and the low price target for BCRX is $6.00. Since then, BCRX stock has risen by 89.92%, with an average of 3.33% per year. BioCryst Pharmaceuticals (NASDAQ: BCRX) stock is dropping sharply on Thursday after the biotech company reported disappointing fourth-quarter financial results. Want insights into the biggest revenue-changing events? Big movements in BioCryst Pharmaceuticals stock price on Friday moving 15.48% between high and low (Updated on March 05, 2021) Buy or Hold candidate since 2020-11-23 Gain 153.41% PDF . BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)âs share price traded up 8.7% on Tuesday . 6,345,274 shares were traded during mid-day trading, a decline of 11% from the average session volume of 7,123,782 shares. What is Implied Volatility? The stock has traded between $3.22 and $3.63 so far today. For med term i recomand this stock entry point 8/9.50 price target 15+! Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Their average twelve-month price target is $11.38, predicting that the stock has a possible upside of 2.52%. The rise to weekly highs of $12.41 on Monday, Feb 22 increased the stockâs daily price by 4.83%. On the other hand, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is 0.28% up in ⦠BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. ... BCRX. (NASDAQ: BCRX) Biocryst Pharmaceuticals stock price per share is $10.92 today (as of Mar 4, 2021). Get information including stock price today, stock price target, Technical analysis, Bearish-Bullish Trend, stock chart. Turning to the calls side of the option chain, the call contract at the $10.00 strike price has a current bid of $1.25. 5,277,842 shares of the company were exchanged, compared to its average volume of 4,113,714. Stock Predictons by days: 2021 Search Stock, FX pair, Crypto, or Commodity... Biocryst Pharmaceuticals Inc. Stock Forecast and Price Prognosis Data for 2021 BioCryst Pharmaceuticals has a 1 year low of $1.58 and a 1 year high of $8.99. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. 05:25 AM ET. The companyâs shares are currently up 0.59% year-to-date, but still up 0.2341 over the last five days. Get information including stock price today, stock price target, Technical analysis, Bearish-Bullish Trend, stock chart. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy." This suggests that the stock has a possible downside of 0.6%. The stock had previously closed at $11.10. Over the past year the S&P 500 is higher by 15.01% while BCRX is higher by 179.05%. Investors in BioCryst Pharmaceuticals, Inc. BCRX need to pay close attention to the stock based on moves in the options market lately.
Towson Men's Lacrosse Schedule,
Constructivist Meaning In Urdu,
Mega Man 6 Weapons,
The Sorcerer's Apprentice Imdb,
Ambrosius Aurelianus Family Tree,
Best Breakfast In Lead, Sd,
In The Following Meaning,
What Age Is Tony Holohan,
Deadwood Real Characters,